Stock Analysts

IMAX’s Q4 Earnings Miss, Revenues Beat Estimates, Down Y/Y

IMAX Corporation IMAX delivered fourth-quarter 2018 adjusted earnings of 26 cents per share, which missed the Zacks Consensus Estimate by a penny and declined 23.5% year over year. Total revenues of $108.9 million surpassed the Zacks Consensus Estimate of $101.4 million. However, the figure declined 13.2% from the year-ago quarter […]

Stock Analysts

JPMorgan Affirms Profitability Goals, Expects Costs to Rise

Being one of the biggest global banks with exposure to almost all major banking businesses, JPMorgan ’s JPM annual Investors Day conference is closely watched by investors to gauge the performance of the overall banking sector. One important question in investors’ mind at present is the impending economic slowdown and its impact on banking industry. While keeping its medium-term profitability goal of 17% return on tangible equity intact, JPMorgan cautioned about a slowdown in lending […]

Stock Analysts

Ophthotech’s (OPHT) Q4 Loss Wider, Gene Therapy in Focus

Ophthotech Corporation OPHT reported adjusted loss of 53 cents per share in fourth-quarter 2018, wider than the Zacks Consensus Estimate of 37 cents and the year-ago figure of 26 cents. The adjusted loss excluded gain on extinguishment of royalty purchase liability due to the termination of the company’s royalty purchase and sale agreement in December 2018 with Novo Holdings A/S, a holding company for Novo Nordisk NVO . With no approved products in its portfolio, Ophthotech derives revenues from milestone and other payments under collaborations. […]